TRCT
CELGZ

Tower Research Capital (TRC)’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Tower Research Capital (TRC)’s Portfolio CELGZ Stock Details CELGZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-14
Closed – – 4747
2019
Q1 		$0 Sell
14
-396
-97% -$387 ﹤0.01% 4734
2018
Q4 		$0 Sell
410
-590
-59% -$538 ﹤0.01% 4792
2018
Q3 		$2K Buy
+1,000
New +$1.33K ﹤0.01% 3540
2016
Q4 		– Sell
-800
Closed -$1K – 4971
2016
Q3 		$1K Sell
800
-100
-11% -$121 ﹤0.01% 3509
2016
Q2 		$1K Buy
900
+100
+13% +$129 ﹤0.01% 4344
2016
Q1 		$1K Sell
800
-1,161
-59% -$1.55K ﹤0.01% 3975
2015
Q4 		$2K Sell
1,961
-210
-10% -$280 ﹤0.01% 3966
2015
Q3 		$3K Buy
2,171
+1,123
+107% +$2.17K ﹤0.01% 3264
2015
Q2 		$2K Sell
1,048
-138
-12% -$353 ﹤0.01% 3905
2015
Q1 		$4K Sell
1,186
-454
-28% -$1.44K ﹤0.01% 3502
2014
Q4 		$5K Sell
1,640
-72
-4% -$243 ﹤0.01% 2812
2014
Q3 		$6K Sell
1,712
-429
-20% -$1.25K ﹤0.01% 3238
2014
Q2 		$6K Buy
2,141
+20
+0.9% +$55 ﹤0.01% 2807
2014
Q1 		$6K Buy
2,121
+143
+7% +$432 ﹤0.01% 3202
2013
Q4 		$5K Buy
1,978
+1,213
+159% +$3.4K ﹤0.01% 3617
2013
Q3 		$6K Sell
765
-169
-18% -$1.3K ﹤0.01% 3626
2013
Q2 		$7K Buy
+934
New +$6.77K ﹤0.01% 2770

Other funds holding CELGZ

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
FA
FCG Advisors Chatham, New Jersey $425M AUM 12.09% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return
BFA
Beaumont Financial Advisors Needham, Massachusetts $1.46B AUM 21.07% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Tower Research Capital (TRC)'s CELGZ Position: Q2 2019 in Review

Tower Research Capital (TRC) sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q2 2019, closing a stake of 14 shares.

Tower Research Capital (TRC) first reported a position in CELGZ in Q2 2013 and held it in 17 quarters. The position peaked at $7K in Q2 2013. 20 funds tracked by Wall St. Rank hold CELGZ as of Q2 2019.

  • Tower Research Capital (TRC) reported no remaining Celgene Corporation Contingent Value Rights position as of Q2 2019 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 14 Celgene Corporation Contingent Value Rights shares in Q2 2019.
  • Tower Research Capital (TRC) first reported a position in Celgene Corporation Contingent Value Rights in Q2 2013 and held it in 17 quarters.
  • Tower Research Capital (TRC)'s Celgene Corporation Contingent Value Rights position peaked at $7K in Q2 2013.
  • 20 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q2 2019.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.